01—Abstract
Summary
Summary of the 8-K filed April 26, 2024. Cited figures are marked; the original filing is the authoritative source.
At its April 24, 2024 Annual Meeting, Bank of America's shareholders approved an amendment and restatement of the Bank of America Corporation Equity Plan (BACEP) that increases the number of shares available for grant by 100 million.
The plan's other terms are substantially unchanged. Per the proxy materials, about 67 million shares were available for grant as of March 1, 2024, and the company expects the additional 100 million to last roughly one year at current grant practices. Shareholders approved the plan with about 78%a of votes cast (excluding broker non-votes), and the estimated incremental overhang from the increase is about 1.3%, with total fully diluted overhang of about 5.3%.
The other matters on the ballot went as management recommended. All 13 director nominees were elected, though Maria T. Zuber received the most against votes (about 348 million).
The advisory say-on-pay resolution passed with roughly 91%b of votes cast in favor, and PricewaterhouseCoopers LLP was ratified as the independent auditor for 2024 with about 95% support. Shareholders rejected all ten shareholder proposals. The most supported was the request for an independent board chair, at about 31% of votes cast, followed by the lobbying-alignment proposal at about 27%.
For investors, this 8-K is a governance and compensation event rather than a financial disclosure. It contains no earnings, capital, or guidance information. The key takeaways are that the equity plan expansion is primarily a dilution and compensation-tool decision, that the company positions it as necessary to keep paying variable compensation in deferred stock rather than cash, and that shareholder dissatisfaction on ESG and governance topics did not reach majority support.
02—Key points
Key Highlights
- Shareholders approved an amendment and restatement of the BACEP adding 100 million shares for grant, with about 78% of votes cast in favor.
- Pre-amendment availability was about 67 million shares as of March 1, 2024, which management says would last less than one year at current grant practices.
- Estimated fully diluted overhang is 5.3% after the increase, with the incremental overhang from the new shares about 1.3%.
- Say-on-pay passed with about 91% of votes cast in favor, and the PwC auditor ratification passed with about 95% support.
- All 13 director nominees were elected, with Maria T. Zuber drawing the most against votes (about 348 million).
- All ten shareholder proposals failed; the independent board chair proposal received the most support at about 31% of votes cast.
- The plan expires April 24, 2033, and the company states it has not granted stock options or SARs since 2008.
03—Questions
Frequently Asked Questions
What exactly did shareholders approve?
Shareholders approved an amendment and restatement of the Bank of America Corporation Equity Plan that increases the number of shares of common stock available for awards by 100 million. The company says the plan's other terms are substantially unchanged, and the proxy describes no other material changes.
Why does the company need more shares, and how long will they last?
The company says the existing pool of roughly 67 million shares (as of March 1, 2024) would last less than a year at current grant practices. Management says the additional 100 million shares would let it keep granting deferred equity awards in lieu of cash for approximately one year. The board said the alternative would be more deferred cash awards, which it believes would reduce alignment with shareholders.
How much dilution does this create for shareholders?
The company estimates total overhang from the BACEP and legacy plans at about 5.3% on a fully diluted basis, based on data as of March 1, 2024. The incremental overhang from the 100 million share increase is about 1.3%. The company also states that it repurchases shares at least equal to the value of stock-settled awards as they are recognized, which it says offsets the dilution.
Did any shareholder proposals pass, and what do the votes signal?
No shareholder proposals passed. The strongest was the request for an independent board chair, at roughly 31% of votes cast, followed by the lobbying-alignment proposal at roughly 27%. The votes suggest meaningful investor interest in governance and climate-related topics, but not majority support for these changes.
04—Continue